Last reviewed · How we verify

NCT04969484: ImPAcTT

Improving Palliative Care Access Through Technology

Suspended NA Last updated 20 July 2021
What this trial tests

NA trial testing Telehealth visit in Telehealth in 81 participants. Suspended.

Timeline
19 February 2018
Primary endpoint
30 June 2022
30 June 2022

Quick facts

Lead sponsorUniversity of Utah
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment81
Start date19 February 2018
Primary completion30 June 2022
Estimated completion30 June 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Utah

Who can join

18 and older, any sex, with Telehealth or Palliative Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will focus on developing, optimizing and pilot-testing a multi-component Improving Access Through Technology (ImPAcTT) intervention that leverages existing telehealth technologies to provide staff education; family outreach, engagement and support; care coordination; and resident symptom management and facilitation of goals-of-care discussion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Telehealth visit

Trials testing the same drug.

Other recruiting trials for Telehealth

Currently open trials in the same condition.

Other University of Utah trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing